(7) revealed that FAM83A overexpression induced resistance to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), leading to the breast cancer patients’ poor prognosis (8). The gene discussed is EGFR; the disease is breast carcinoma.